Drugs & Therapy Perspectives | 2001(17) articles
- Donepezil for the management of patients with Alzheimer's disease: a good choice from among the cholinesterase inhibitors
- Will the promise of the COX-2 selective NSAIDs come to fruition?
- Options for managing influenza are increasing
- First reports of adverse drug reactions (ADRs) in recent weeks
- New in the marketplace